Cysteine as a potential anti-amyloidogenic agent with protective ability against amyloid induced cytotoxicity

Masihuz Zaman1, Syed Mohammad Zakariya1, Saima Nusrat1

  • 1Molecular Biophysics and Biophysical Chemistry Group, Interdisciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh, 202002, India.

Insights

Cysteine effectively inhibits protein fibrillation and aggregation, restoring native-like structures. This finding offers potential therapeutic strategies for protein misfolding disorders.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Biophysics

Background:

  • Protein misfolding and aggregation are implicated in various human diseases.
  • Inhibiting protein aggregation is a key research focus for disease treatment.

Purpose of the Study:

  • To investigate the anti-fibrillation and anti-aggregation properties of cysteine.
  • To understand cysteine's effect on the kinetics of stem bromelain amyloid fibril formation.

Main Methods:

  • Turbidity measurements
  • Thioflavin T (ThT) and Anilino-naphthalene-sulfonic acid (ANS) dye binding assays
  • Circular Dichroism (CD) spectroscopy
  • Electron Microscopy
  • Dynamic Light Scattering (DLS)
  • Isothermal Titration Calorimetry (ITC)

Main Results:

  • Cysteine demonstrated concentration-dependent inhibition of temperature-induced protein fibrillation.
  • Cysteine treatment increased the viability of MDA-MB-231 cells exposed to pre-formed amyloid fibrils.
  • DLS studies indicated that cysteine restores stem bromelain to native-like structures.
  • ITC results suggested that hydrogen bonding and thiophilic interactions are crucial for cysteine's inhibitory mechanism.

Conclusions:

  • Cysteine exhibits significant anti-fibrillation and anti-aggregation activities against stem bromelain.
  • Cysteine's mechanism involves restoring protein structure and potentially offers therapeutic benefits for protein misfolding diseases.